NAVB Navidea Biopharmaceuticals Inc

Navidea Biopharmaceuticals Inc is a biotechnology company engaged in precision medicine. Its products are designed to assist in the identification of undetected diseases and develop treatment for cancer, autoimmune conditions, and inflammatory diseases.

$0.85  -0.02 (-1.73%)
As of 05/26/2022 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/10/1992
Outstanding shares:  30,359,792
Average volume:  46,096
Market cap:   $26,261,220
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   -2.94
PB ratio:   7.52
PS ratio:   64.40
Return on equity:   489.24%
Net income %:   -2,881.80%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy